药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Hydrocortamate
Zopiclone
The metabolism of Zopiclone can be decreased when combined with Rabeprazole.
Hydrocortamate
Tofacitinib
The metabolism of Tofacitinib can be decreased when combined with Rabeprazole.
Hydrocortamate
Retapamulin
The metabolism of Retapamulin can be decreased when combined with Rabeprazole.
Hydrocortamate
Iloperidone
The metabolism of Iloperidone can be decreased when combined with Rabeprazole.
Hydrocortamate
Colchicine
The metabolism of Colchicine can be decreased when combined with Rabeprazole.
Hydrocortamate
Luliconazole
The serum concentration of Rabeprazole can be increased when it is combined with Luliconazole.
Hydrocortamate
Saquinavir
The serum concentration of Saquinavir can be increased when it is combined with Rabeprazole.
Hydrocortamate
Risedronic acid
Rabeprazole can cause an increase in the absorption of Risedronic acid resulting in an increased serum concentration and potentially a worsening of adverse effects.
Hydrocortamate
Riociguat
Rabeprazole can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy.
Hydrocortamate
Rilpivirine
Rabeprazole can cause a decrease in the absorption of Rilpivirine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Hydrocortamate
Raltegravir
Rabeprazole can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects.
Hydrocortamate
Posaconazole
Rabeprazole can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Hydrocortamate
Pazopanib
Rabeprazole can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Hydrocortamate
Nilotinib
The serum concentration of Rabeprazole can be decreased when it is combined with Nilotinib.
Hydrocortamate
Dexmethylphenidate
Rabeprazole can cause an increase in the absorption of Dexmethylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.
Hydrocortamate
Ledipasvir
Rabeprazole can cause a decrease in the absorption of Ledipasvir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Hydrocortamate
Itraconazole
Itraconazole can cause a decrease in the absorption of Rabeprazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Hydrocortamate
Dextroamphetamine
Rabeprazole can cause an increase in the absorption of Dextroamphetamine resulting in an increased serum concentration and potentially a worsening of adverse effects.
Hydrocortamate
Dasatinib
Rabeprazole can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Hydrocortamate
Dabigatran etexilate
Rabeprazole can cause a decrease in the absorption of Dabigatran etexilate resulting in a reduced serum concentration and potentially a decrease in efficacy.